Protein phosphatase 2 (PP2A) downregulates Nox2 expression, with inhibition of PP2A in rats being shown to exacerbate non-alcoholic steatohepatitis (a disease associated with metabolic syndrome and type 2 diabetes mellitus) [59]. Here, PTPA is linked to metabolic dysfunction-associated steatohepatitis.